Medtronic (MDT) Reports In-Line Q3 EPS; Guides Q4 In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Medtronic, Inc. (MDT) PT Lowered to $124 at Needham & Company
February 22, 2022 1:59 PM ESTNeedham & Company analyst Michael Matson lowered the price target on Medtronic, Inc. (NYSE: MDT) to $124.00 (from $128.00) while maintaining a Buy rating following earnings.
The analyst commented, "MDT's F3Q22 revenue missed consensus while its EPS beat consensus and organic revenue growth slowed... More
